Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Chronic Heart Failure

  Free Subscription


27.05.2019

1 Am Heart J
2 Cardiovasc Res
1 Chest
2 Circ Heart Fail
8 Circ Res
3 Circulation
1 Clin Cardiol
1 Eur Heart J
7 Eur J Heart Fail
2 Heart
3 Int J Cardiol
1 J Thorac Cardiovasc Surg
2 PLoS Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. AKERBLOM A, Wojdyla DM, Wallentin L, James SK, et al
    Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
    Am Heart J. 2019;213:57-65.
    PubMed     Text format     Abstract available


    Cardiovasc Res

  2. KONEMANN S, Sartori LV, Gross S, Hadlich S, et al
    Cardio-protective effect of the secretome of Sca-1+ and Sca-1- cells in heart failure - not equal, but equally important?
    Cardiovasc Res. 2019 May 22. pii: 5497483. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. ZIEGLER KA, Ahles A, Wille T, Kerler J, et al
    Local sympathetic denervation attenuates myocardial inflammation and improves cardiac function after myocardial infarction in mice.
    Cardiovasc Res. 2017 Nov 24. pii: 4657089. doi: 10.1093.
    PubMed     Text format     Abstract available


    Chest

  4. SINGH I, Rahaghi FN, Naeije R, Oliveira RKF, et al
    Right ventricular-arterial uncoupling during exercise in heart failure with preserved ejection fraction - role of pulmonary vascular dysfunction.
    Chest. 2019 May 16. pii: S0012-3692(19)31057-8. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  5. SEKULIC M, Zacharias M, Medalion B
    Ischemic Cardiomyopathy and Heart Failure.
    Circ Heart Fail. 2019;12:e006006.
    PubMed     Text format    

  6. FERREIRA JP, Verdonschot J, Collier T, Wang P, et al
    Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.
    Circ Heart Fail. 2019;12:e005897.
    PubMed     Text format     Abstract available


    Circ Res

  7. HUSSEIN AA, Wilkoff BL
    Cardiac Implantable Electronic Device Therapy in Heart Failure.
    Circ Res. 2019;124:1584-1597.
    PubMed     Text format     Abstract available

  8. WILLERSON JT
    The Medical and Device-Related Treatment of Heart Failure.
    Circ Res. 2019;124:1519.
    PubMed     Text format    

  9. MILLER L, Birks E, Guglin M, Lamba H, et al
    Use of Ventricular Assist Devices and Heart Transplantation for Advanced Heart Failure.
    Circ Res. 2019;124:1658-1678.
    PubMed     Text format     Abstract available

  10. PINILLA-VERA M, Hahn VS, Kass DA
    Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.
    Circ Res. 2019;124:1618-1632.
    PubMed     Text format     Abstract available

  11. HEALLEN TR, Kadow ZA, Kim JH, Wang J, et al
    Stimulating Cardiogenesis as a Treatment for Heart Failure.
    Circ Res. 2019;124:1647-1657.
    PubMed     Text format     Abstract available

  12. ZELT JGE, Chaudhary KR, Cadete VJ, Mielniczuk LM, et al
    Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.
    Circ Res. 2019;124:1551-1567.
    PubMed     Text format     Abstract available

  13. PFEFFER MA, Shah AM, Borlaug BA
    Heart Failure With Preserved Ejection Fraction In Perspective.
    Circ Res. 2019;124:1598-1617.
    PubMed     Text format     Abstract available

  14. ELGENDY IY, Mahtta D, Pepine CJ
    Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.
    Circ Res. 2019;124:1520-1535.
    PubMed     Text format     Abstract available


    Circulation

  15. BENFARI G, Antoine C, Miller WL, Thapa P, et al
    Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
    PubMed     Text format     Abstract available

  16. VAN DER MEER P, van der Wal HH, Melenovsky V
    Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure.
    Circulation. 2019;139:2399-2402.
    PubMed     Text format    

  17. TESTANI JM, Inzucchi SE, Voors AA
    Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?
    Circulation. 2019;139:2383-2385.
    PubMed     Text format    


    Clin Cardiol

  18. PAVLUSOVA M, Jarkovsky J, Benesova K, Vitovec J, et al
    Hyperuricaemia treatment in acute heart failure patients does not improve their long-term prognosis: a propensity score matched analysis from the AHEAD registry.
    Clin Cardiol. 2019 May 22. doi: 10.1002/clc.23197.
    PubMed     Text format     Abstract available


    Eur Heart J

  19. PACKER M
    Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey.
    Eur Heart J. 2019 May 23. pii: 5497835. doi: 10.1093.
    PubMed     Text format    


    Eur J Heart Fail

  20. BLANKINSHIP D, Katz MR, Lozonschi L, Tedford RJ, et al
    Pulmonary artery wedge pressure respiratory variation is correlated with haemodynamic improvement with increased left ventricular assist system speed.
    Eur J Heart Fail. 2019;21:251-253.
    PubMed     Text format    

  21. PACKER M
    The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal range.
    Eur J Heart Fail. 2019;21:156-162.
    PubMed     Text format     Abstract available

  22. METRA M
    January 2019 at a glance: prognostic assessment, left ventricular assist devices, disease management and quality of care.
    Eur J Heart Fail. 2019;21:1-2.
    PubMed     Text format    

  23. METRA M
    February 2019 at a glance: pathophysiology, exercise capacity, diuretics and valve disease.
    Eur J Heart Fail. 2019;21:135-136.
    PubMed     Text format    

  24. SEFEROVIC PM, Seferovic JP, Polovina MM
    Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes.
    Eur J Heart Fail. 2019 May 21. doi: 10.1002/ejhf.1500.
    PubMed     Text format    

  25. SENNI M, Adamo M, Metra M, Alfieri O, et al
    Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?
    Eur J Heart Fail. 2019 May 22. doi: 10.1002/ejhf.1491.
    PubMed     Text format     Abstract available

  26. DOEHNER W, von Haehling S
    Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency.
    Eur J Heart Fail. 2019 May 22. doi: 10.1002/ejhf.1496.
    PubMed     Text format    


    Heart

  27. SCHICHTEL M, Wee B, Perera R, Onakpoya I, et al
    Clinician-targeted interventions to improve advance care planning in heart failure: a systematic review and meta-analysis.
    Heart. 2019 May 22. pii: heartjnl-2019-314758. doi: 10.1136/heartjnl-2019-314758
    PubMed     Text format     Abstract available

  28. CLARK AL, Kalra PR, Petrie MC, Mark PB, et al
    Change in renal function associated with drug treatment in heart failure: national guidance.
    Heart. 2019;105:904-910.
    PubMed     Text format     Abstract available


    Int J Cardiol

  29. OKUTUCU S, Bursa N
    Effect of sacubitril/valsartan on cardiac filling pressures in patients with heart failure: Suggestions for statistical analysis.
    Int J Cardiol. 2019;288:117.
    PubMed     Text format    

  30. GULEA C, Zakeri R, Quint JK
    Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.
    Int J Cardiol. 2019 Apr 30. pii: S0167-5273(19)31403.
    PubMed     Text format     Abstract available

  31. OIKAWA T, Sakata Y, Nochioka K, Miura M, et al
    Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
    Int J Cardiol. 2019 Apr 26. pii: S0167-5273(18)36322.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  32. TANG PC, Haft JW, Romano MA, Bitar A, et al
    Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    J Thorac Cardiovasc Surg. 2019 Apr 5. pii: S0022-5223(19)30774.
    PubMed     Text format     Abstract available


    PLoS Med

  33. CONRAD N, Judge A, Canoy D, Tran J, et al
    Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients.
    PLoS Med. 2019;16:e1002805.
    PubMed     Text format     Abstract available

  34. ANWAR MS, Japp AG, Mills NL
    Heart failure and healthcare informatics.
    PLoS Med. 2019;16:e1002806.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: